NCT01096485View on ClinicalTrials.gov

Cross-over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions

ContraceptionContraception, Postcoital

Interventions

DRUG

Levonorgestrel Emergency Pill (BAY86-5028/Opxion)

Single dose of 1.5 mg coated tablet

DRUG

Levonorgestrel (Postday)

Single dose of two 0.75 mg tablets

Trial Locations (1)

58256

Morelia

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY